PVALB and Alzheimer disease: While studies have shown significant drops in somatostatin-positive interneurons in the cortex of AD patients [65, 66], the numbers of parvalbumin-positive cortical interneurons, including the PVALB+ chandelier cells, appear comparatively more resilient to AD pathology [66, 67].